A review of radiation dose escalation trials for non-small cell lung cancer within the Radiation Therapy Oncology Group

Seminars in Oncology

Volumn 32, Issue SUPPL. 3, 2005, Pages 111-113

  Bradley, Jeffrey ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; PACLITAXEL; VINBLASTINE;

ACUTE TOXICITY; AUTOIMMUNITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; ESOPHAGUS DISEASE; ESOPHAGUS FISTULA; GAMMA RADIATION; HEMOPTYSIS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; MAXIMUM PERMISSIBLE DOSE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; TREATMENT OUTCOME; LUNG TUMOR; MULTIMODALITY CANCER THERAPY; REVIEW;

CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; RADIOTHERAPY DOSAGE;

EID: 18144423503     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2005.03.020     Document Type: Conference Paper

References (7)

1. W. Curran, C. Scott, C. Langer Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresectable NSCLC RTOG 9410 Proc Am Soc Clin Oncol 22 2003 621a (abstr 2499)
2. C.A. Perez, K. Stanley, P. Rubin A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat cell carcinoma of the lung Preliminary report by the Radiation Therapy Oncology Group Cancer 45 1980 2744 2753
3. T. LeChevalier, R. Arriagada, E. Quoix Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer First analysis of a randomized trial in 353 patients J Natl Cancer Inst 83 1991 417 423
4. G. Fletcher Clinical dose-response curves of human malignant epithelial tumours Br J Radiol 46 1973 1 12
5. W.J. Curran, C. Scott, C. Langer Phase III comparison of sequential vs concurrent chemoradiation for patients with unresected stage III non-small cell lung cancer (NSCLC) Initial report of Radiation Therapy Oncology Group (RTOG) 9410 Proc Am Soc Clin Oncol 19 2000 1891a (abstr 1891)
6. J. Bradley, M. Graham, K. Winter Toxicity and outcome results of RTOG 9311 A phase I-II dose escalation study using three-dimensional conformal radiation therapy in patients with inoperable non-small cell lung carcinoma Int J Radiat Oncol Biol Phys 61 2005 318 328
7. M.V. Graham, J.A. Purdy, B. Emami Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys 45 1999 323 329